Ads
    Related paper
  1. A COMPARATIVE ASSESSMENT OF THE EFFECT OF MINERALOCORTICOID RECEPTOR ANTAGONISTS ON CHANGES IN GALECTIN-3 AND MMP-1 FIBROSIS MARKERS IN PATIENTS WITH CCF COMBINED WITH TYPE 2 DM WITH MANIFESTATIONS OF MYOCARDIUM DYSSYNCHRONY
  2. FEATURES OF ECHOCARDIOGRAPHIC AND ELECTROCARDIOGRAPHIC PARAMETERS OF MЕСHANICAL DYSSYNCHRONY IN PATIENTS WITH HEART FAILURE COMBINED WITH TYPE 2 DIABETES
  3. DAMAGE OF RENAL FUNCTION AND DYNAMICS OF DYSLIPIDEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH INSUFFICIENT GLYCEMIC COMPENSATION UNDER CONDITION OF CORRECTION OF HYPERTENSION WITH ANGIOTENSIN II RECEPTOR ANTAGONISTS
  4. Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
  5. EFFECT OF HEMOSORPTION WITH EXTRACORPOREAL AUTOHEMOMAGNETIC THERAPY VERSUS DRUG THERAPY WITH IL-6 RECEPTOR ANTAGONISTS ON CLINICAL AND LABORATORY PARAMETERS OF PATIENTS WITH SEVERE COVID-19
  6. Therapy Effect on the Levels of Inflammation Biomarkers P-Selectin and Galectin-3 in Patients with Stable Angina Pectoris and Type 2 Diabetes Mellitus
  7. Clinical Characteristics in Combined Pulmonary Fibrosis and Emphysema Syndrome vs Idiopathic Pulmonary Fibrosis Patients
  8. FIBROTIC CHANGES IN PATIENTS WITH CHRONIC HEART FAILURE WITH CARDIAC DYSSYNCHRONY AND ASSOCIATED TYPE 2 DIABETES MELLITUS
  9. ASSESSMENT OF PROINFLAMMATORY MARKERS IN TYPE 2 DIABETIC PATIENTS POSTCOVID-19 VACCINATION
  10. CLINICAL AND BIOCHEMIICAL MANIFESTATIONS OF VITAMIN B12 DEFICIENCY IN TYPE 2 DIABETIC PATIENTS TREATED WITH METFORMIN- A COMPARATIVE STUDY